April 28, 2020 / 8:48 PM / a month ago

BRIEF-Ironwood, Allergan Receive Notices Of Allowance For Patent Applications Covering 72 MCG Dose Of Linzess

April 28 (Reuters) - Allergan plc:

* IRONWOOD AND ALLERGAN RECEIVE NOTICES OF ALLOWANCE FOR PATENT APPLICATIONS COVERING 72 MCG DOSE OF LINZESS® (LINACLOTIDE)

* IRONWOOD PHARMACEUTICALS INC - NEW PATENTS EXPECTED TO PROVIDE COVERAGE FOR 72 MCG DOSE INTO 2031 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below